Status:
COMPLETED
Detection and Classification of Diabetic Retinopathy From Posterior Pole Images With A Deep Learning Model
Lead Sponsor:
Ural Telekomunikasyon Sanayi Ticaret Anonim Sirketi
Collaborating Sponsors:
Akdeniz University
Conditions:
Diabetic Retinopathy
Diabetic Eye Problems
Eligibility:
All Genders
18+ years
Brief Summary
The duration of diabetes is directly related to eye complications. Diabetic retinopathy affects 80 percent of those who have had diabetes for 20 years or more. At least 90% of new cases can be reduced...
Detailed Description
This is a prospective study to assess the safety and efficacy of EyeCheckup in screening for DR. This study was carried out in a single center at Akdeniz University Faculty of Medicine with primary e...
Eligibility Criteria
Inclusion
- A diagnosis of diabetes mellitus
- Understanding of study and provision of written informed consent
- 18 years of age or older
- No history of any other retinal vascular disease, glaucoma, or other disease that may affect the appearance of the retina or optic disc (refractive error and ocular surface disease are allowed)
- Other than cataract surgery, no history of intraocular surgery, ocular laser treatments for any retinal disease, or ocular injections for diabetic macular edema or proliferative disease No media opacity precluding good retinal photography
Exclusion
- No diagnosis of diabetes mellitus
- Potential subject cannot understand study or informed consent
- A history of retinal vascular disease other than diabetic retinopathy that may affect the appearance of the retina or optic disc
- Previous intraocular surgery including cataract; previous laser to the retina; or previous intraocular injections for the treatment of diabetic retinopathy
- Pregnant women or women with gestational diabetes mellitus
- A media opacity in either eye that is severe enough to preclude good retinal photography
- Permanent vision impairment in one or both eyes
- The participant is contraindicated for imaging with fundus imaging systems used in the study:
- Participant is hypersensitive to light
- Participant recently received photodynamic therapy (PDT)
- Participant uses drugs that cause photosensitivity
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 4 2022
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT04805541
Start Date
February 1 2022
End Date
July 4 2022
Last Update
July 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Akdeniz University Hospital
Antalya, Turkey (Türkiye), 07070